Comprehensive Genomic Profiling for Non-Small-Cell Lung Cancer: Health and Budget Impact

Abstract

Given the present testing landscape for patients with nsclc in Canada, listing cgp testing could optimize the selection of appropriately targeted treatments, and thus add life-years and productivity for this population, with a minimal budget impact.